Clonal lineage tracing and parallel multiomics profiling reveal transcriptional heterogeneity induced by ARID1A deficiency
Open Access
- 9 October 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (41)
Abstract
Transcriptional heterogeneity drives malignant progression, yet how it emerges within tumors remains unclear. By combining genetic perturbation and lineage tracing with parallel single-cell multiomics, we tracked the consequences of ARID1A loss within individual clonal lineages. ARID1A deficiency increased transcriptional variability both within and across clones, recurrently giving rise to diverse transcriptional profiles that did not converge on a common, coordinated pattern. This variability was accompanied by broadened chromatin accessibility at normally silenced loci and depended on residual SMARCA4 activity. Clones in which this variability was prominent showed no growth advantage under standard conditions but were preferentially recovered under specific environmental stresses and during lung colonization, a context dependence consistent with bet-hedging. Our findings suggest that loss of an epigenetic regulator can promote tumor evolution by relaxing transcriptional constraints and widening the range of phenotypes accessible to a clonal lineage, rather than by imposing a single fixed phenotype.Keywords
Funding Information
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Agency for Medical Research and Development (JP24ama221606)
- Japan Society for the Promotion of Science (23K18247)
- Japan Society for the Promotion of Science (23K27446)
- Japan Society for the Promotion of Science (25K22584)
- Japan Society for the Promotion of Science (24K02312)
- Kato Memorial Bioscience Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
This publication has 66 references indexed in Scilit:
- Selective advantage of epigenetically disrupted cancer cells via phenotypic inertiaCancer Cell, 2022
- Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT statesCancer Cell, 2021
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Emergence of a High-Plasticity Cell State during Lung Cancer EvolutionCancer Cell, 2020
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver CancerCancer Cell, 2019
- Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethalityInternational Journal of Cancer, 2018
- KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic ResistanceCancer Cell, 2018
- Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET InhibitorsCancer Cell, 2018
- Tumor evolution: Linear, branching, neutral or punctuated?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2017
- Clonal Heterogeneity and Tumor Evolution: Past, Present, and the FutureCell, 2017